1. Inhibitors of protein: geranylgeranyl transferases.
- Author
-
El Oualid F, Cohen LH, van der Marel GA, and Overhand M
- Subjects
- Alkyl and Aryl Transferases antagonists & inhibitors, Animals, Antineoplastic Agents chemistry, Antineoplastic Agents pharmacology, Drug Design, Humans, Models, Molecular, Molecular Mimicry, Protein Conformation, Proteomics methods, Signal Transduction, Alkyl and Aryl Transferases chemistry, Alkyl and Aryl Transferases metabolism, Enzyme Inhibitors chemistry, Enzyme Inhibitors pharmacology
- Abstract
The enzyme protein:geranylgeranyl transferase-1 (PGGT-1 or GGTase-I) catalyzes the geranylgeranylation of cysteine residues near the C-termini of a variety of proteins, including most monomeric GTP binding precursor proteins belonging to the Rho, Rac and Rap subfamilies. These proteins are involved in signaling pathways controlling important processes such as cell differentiation and growth. In the framework of the development of therapeutics against disorders associated with aberrant cell proliferation, the interference with these signal transduction cascades has been a major focus of investigation. For instance inhibitors of PGGT-1 have shown promise in the treatment of cancer, smooth muscle hyperplasia as well as parasitic infections, such as malaria. In this review, structural and mechanistic aspects of the protein:geranylgeranyl transferases are discussed as well as their importance with respect to the terpene metabolism. An extensive summary of reported inhibitors of PGGT-1, classified as natural products, peptide substrate (Ca(1)a(2)L box), terpene substrate (geranylgeranyl pyrophosphate) and others, is presented. The few known inhibitors of the other geranylgeranylating enzyme, protein:geranylgeranyl transferase-2 (PGGT-2), are also included.
- Published
- 2006
- Full Text
- View/download PDF